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K+ ions play a major role in many cellular processes. The deregulation of K+ signaling is
associated with a variety of diseases such as hypertension, atherosclerosis, or diabetes.
K+ ions are important for setting the membrane potential, the driving force for Ca2+ influx,
and regulate volume of growing cells. Moreover, it is increasingly recognized that K+
channels control cell proliferation through a novel signaling mechanisms triggered and
modulated independently of ion fluxes. In cancer, aberrant expression, regulation and/or
sublocalization of K+ channels can alter the downstream signals that converge on the
cell cycle machinery. Various K+ channels are involved in cell cycle progression and are
needed only at particular stages of the cell cycle. Consistent with this idea, the expression
of Eag1 and HERG channels fluctuate along the cell cycle. Despite of acquired knowledge,
our understanding of K+ channels functioning in cancer cells requires further studies.
These include identifying the molecular mechanisms controlling the cell cycle machinery.
By understanding how K+ channels regulate cell cycle progression in cancer cells, we will
gain insights into how cancer cells subvert the need for K+ signal and its downstream
targets to proliferate.
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INTRODUCTION
Cell homeostasis requires a delicate balance between formation of
new cells by cell proliferation and their elimination by apoptosis.
Cell proliferation involves, at some point, activation of Cl−, K+,
aquaporin, and Ca2+ channels (Pardo, 2004; Lang et al., 2007;
Lehen’kyi et al., 2007). As the respective channel inhibitors have
been reported to interfere with cell proliferation, the channels
appear to play an active role in the machinery triggering cell entry
and progression through the cell cycle (Wonderlin and Strobl,
1996; Ouadid-Ahidouch and Ahidouch, 2008; Becchetti, 2011).
Perturbations in the cell cycle results in unlimited prolif-
eration and confers the apoptosis resistance leading to cancer
development (Malumbres and Barbacid, 2001, 2009). The pro-
gression of cells through the cell cycle is regulated by different
cyclin/Cyclin-Dependent Kinase (CDKs) complexes. The cyclin-
CDK complexes govern a linear progression of the events that
lead cells from a resting state (G0), to growth phase (G1), DNA
replication phase (S), and finally to cell division (M). Cyclins D
(D1, D2, and D3) and their associated CDKs (4/6) are important
during the G1 phase (Caldon et al., 2006). Cyclins E and A, along
with their partner, CDK2, are important for the G1/S phase tran-
sition and S-phase progression, respectively, and cyclins A and
B (with Cdc2) are important for entry of the cells into theM
phase (Schwartz and Shah, 2005). The activity of the cyclin/CDK
complex can be inhibited by Cyclin-Dependent Kinase inhibitors
(CDKi) such as p21WAF1/Cip1 and p27kip1 (Besson et al., 2008).
Over the past two decades, ion channels have been identi-
fied as important contributors to cell proliferation of normal
and cancerous cells (for review see Wonderlin and Strobl, 1996;
Kunzelmann, 2005). Otherwise, K+ channels are thought to be
important for setting the membrane potential and the driving
force for Ca2+ influx and both mechanisms are considered cru-
cial for volume regulation of growing cells (Nilius and Wohlrab,
1992; Kunzelmann, 2005; Lang et al., 2007; Ouadid-Ahidouch
and Ahidouch, 2008). Moreover, it is increasingly recognized that
K+ channels control cell proliferation through a novel signaling
mechanisms triggered and modulated independently from ion
fluxes (Hegle et al., 2006; Kaczmarek, 2006; Glassmeier et al.,
2012).
Although the K+ channels contribute to regulation of dif-
ferent cell cycle checkpoints in cancer cells, no direct evidence
about the mechanism at issue has been provided concerning how
they control the cell cycle machinery, particularly in regard to
CDKi and/or cyclin expression (Evan and Vousden, 2001). This
review focuses on the regulation of proliferation by K+ channel-
mediated signals and discusses how these signals may influence
the cell cycle progression in tumor cells.
K+ CHANNELS AND CELL PROLIFERATION
K+ channels belong to a large and heterogeneous group of ion
channels. The first K+ currents were described by Hodgkin and
Huxley in the early 50s during their work on the identification of
ionic species responsible for the propagation of the action poten-
tial in the squid giant axon. Today, several types of K+ channels
have been identified by molecular cloning. They are responsible
for the passive diffusion of K+ ion across the plasma mem-
brane and are detectable in both excitable and non-excitable cells.
K+ channels play a major role in several physiological functions
such as synaptic transmission, muscle contraction, release of hor-
mones, such as insulin (for review see Sandhiya andDkhar, 2009),
or in proliferation, apoptosis, migration, invasion, and angiogen-
esis (Pardo, 2004; Cherubini et al., 2005; Ouadid-Ahidouch and
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Ahidouch, 2008; Schwab et al., 2008; Becchetti, 2011; Cuddapah
and Sontheimer, 2011; Jehle et al., 2011; Girault et al., 2012).
The physiological importance of K+ channels is undoubtedly
underscored considering the increasing number of genetic dis-
eases associated with them. Indeed, Kv gene mutations trigger
episodic ataxia, long QT syndrome, pancreatic diseases, and
epilepsy (Ashcroft and Gribble, 2000; Goonetilleke and Quayle,
2012).
The early studies that have linked K+ channels to the pro-
liferative processes were carried on T lymphocytes (DeCoursey
et al., 1984; Matteson and Deutsch, 1984). In cancer, the first
works were performed onmelanoma cells, neuroblastoma, breast,
lung, and bladder cancer cells (Rouzaire-Dubois and Dubois,
1990; Lepple-Wienhues et al., 1996; Wonderlin and Strobl, 1996;
Ouadid-Ahidouch and Ahidouch, 2008). Since then, a wide vari-
ety of K+ channels has been shown to be implicated in the regu-
lation of proliferation of myeloid leukemia, prostate, colon, neck,
and head cancer, lymphoma and hepatocarcinoma cells (Zhou
et al., 2003; Conti, 2004; Pardo, 2004; Wang, 2004; Kunzelmann,
2005; Wang et al., 2007a; Arcangeli et al., 2009; Jehle et al.,
2011; Lehen’kyi et al., 2011). These data are based on the fact
that, in vitro, genetic or pharmacological inhibition of K+ chan-
nels inhibits the growth of cancer cells. Moreover, K+ channel
openers can also be responsible for an increase in proliferation
rate. Indeed, minoxidil or cromakalim increased activity of KATP
channels inducing an increase in DNA synthesis (Malhi et al.,
2000). KCa3.1 channels activator, 1-EBIO, increased prostate can-
cer cell proliferation (Parihar et al., 2003), but diminished the
proliferative effect on keratinocytes (Koegel et al., 2003).
Several hypotheses argue in favor of a mechanism of K+
influence on the cell cycle involving Ca2+ signaling, membrane
potential, and cell volume (Nilius and Wohlrab, 1992; Lepple-
Wienhues et al., 1996; Wonderlin and Strobl, 1996; Kunzelmann,
2005; Higashimori and Sontheimer, 2007; Zhanping et al., 2007;
Ouadid-Ahidouch and Ahidouch, 2008; Blackiston et al., 2009;
Becchetti, 2011).
One of the most accredited models is based on the involve-
ment of K+ channels in the regulation of membrane potential,
which drives cancer cells into certain phases of the cell cycle. In
cancer cells, it has been shown that cells in the early G1 phase
are depolarized; however, they are hyperpolarized during the pro-
gression through G1 and into the S phase (Wang et al., 1998).
Inhibition of K+ channels or blocking cells in G1 phase by serum
starvation is accompanied by membrane depolarization (Nilius
and Wohlrab, 1992; Wonderlin et al., 1995; Wang et al., 1998;
Ouadid-Ahidouch et al., 2001). Similarly, membrane depolariza-
tion caused by an increase in the concentration of extracellular
K+ mimics the effects of K+ channel blockers (Freedman et al.,
1992).
Many K+ channels have been implicated in the regulation of
the membrane potential, (for review see: Wonderlin and Strobl,
1996; Pardo, 2004; Kunzelmann, 2005; Ouadid-Ahidouch and
Ahidouch, 2008; Becchetti, 2011). In some cases, the membrane
potential of cycling cells is regulated by the ratio of different K+
channel isoforms. For example, in neuroblastoma, the membrane
potential can be controlled by Kv11.1 and blocking this chan-
nel inhibits mitosis (Arcangeli et al., 1995; Crociani et al., 2003;
Becchetti, 2011). In these cells, the membrane potential tends to
depolarize during the S phase. The effect is caused by oscillation
of the expression balance of the full-length Kv11.1a isoform and
the N-deleted Kv11.1b (Crociani et al., 2003). Indeed, the trun-
cated Kv11.1b form is up-regulated during the S phase, while
the full-length Kv11.1a protein increases its expression on the
plasma membrane during the G1 phase (Arcangeli et al., 1995).
The increase of the ratio between Kv11.1b and Kv11.1 leads to
the depolarization of the membrane potential occurring during
S phase progression (Arcangeli et al., 1995).
Ca2+ signaling appears to be required for progression through
G1, the G1/S transition, and G2/M in several cell types (Kahl
and Means, 2003; Roderick and Cook, 2008; Ding et al., 2010).
The relationship between K+ channels, membrane potential, and
Ca2+ influx has been first reported in T cells by Cahalan’s group.
Indeed, the authors proposed that the membrane hyperpolariza-
tion generated by the activation of K+ channels increases the driv-
ing force for Ca2+ influx (Hess et al., 1993; Lewis and Cahalan,
1995), which in turn, activates Ca2+-dependent transcriptional
factors leading to expression of cell cycle regulatory proteins, such
as cyclins, CDKs, and the inhibition of CDKi expression (Nilius
andWohlrab, 1992; Yao and Kwan, 1999; Ouadid-Ahidouch et al.,
2004; Zhanping et al., 2007; Borowiec et al., 2011). The inhibitors
of voltage-gated K+ channels block the Ca2+ influx and the cell
proliferation (Yao and Kwan, 1999; Ouadid-Ahidouch et al., 2004;
Zhanping et al., 2007).
In agreement with these general considerations, in prostate
LNCaP cells, a member of Transient Receptor Potential (TRP)
channel family, TRPV6 was identified as a major provider of pas-
sive calcium influx in response to hyperpolarization associated
with activation of the intermediate-conductance Ca2+-activated
K+ channel (KCa3.1) (Lallet-Daher et al., 2009). The same team
showed that calcium entry through TRPV6 channel in these cells
induced a subsequent downstream activation of Nuclear Factor
Activated T cell (NFAT) leading to cell proliferation (Lehen’kyi
et al., 2007). In breast cancer cells, it was demonstrated that Eag1
(Kv10.1) K+ channel function is required for controlling the Ca2+
entry trough Orai1 channels (Hammadi et al., 2012).
K+ channels also control cellular proliferation by affecting cell
volume (Rouzaire-Dubois et al., 2000). Alterations of cell volume
require participation of ion transport across cell membrane and
accordingly, Cl− and K+ channels (Lang et al., 2007). Recently,
aquaporin channels have emerged as regulators of cell cycle pro-
gression (Di Giusto et al., 2012). Cell volume regulationmay favor
maintenance of appropriate levels of critical cell cycle regulatory
proteins that are necessary for controlling cell cycle progression
through G1 to S or G2/M phases (Tao et al., 2008; Huang et al.,
2012).
In addition to their ability to permit ions to cross the mem-
brane, ion channels can also have non-conducting functions
that enable them to interact with cell signaling pathways to
directly regulate biochemical events (Kaczmarek, 2006). It has
been demonstrated that expression of a mutant form of Eag1,
that cannot conduct current, promotes proliferation of NIH3T3
fibroblasts and C2C12 myoblasts cells (Hegle et al., 2006). In
contrast to the wild type Eag1, the no-conducting Eag1 is inde-
pendent of serum and is unaffected by changes in extracellular
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Ca2+. Moreover, proliferation induced by Eag1 is unaffected by
changes in extracellular Ca2+, suggesting that increased Ca2+
influx is not an essential downstream component of Eag1-
induced signaling. The same authors reported that Eag1 is able to
regulate cell proliferation in fibroblasts via activation of the p38
Mitogen-Activated Protein (MAP) kinase pathway but not extra-
cellular signal-regulated kinase 1/2 (ERK1/2). Ectopic expression
of pore-dead mutant Eag1, in CHO cells, promotes cell growth
in vitro and in vivo (xenografts) (Downie et al., 2008). Recently,
the ion-conducting function of HERG1 has also proved to be
important for cell growth of human small cell lung cancer cells
(Glassmeier et al., 2012). Indeed, the knockdown of HERG1
inhibits cell proliferation, while its pharmacological inhibition by
E4031 fails to affect cell proliferation (Glassmeier et al., 2012).
Additionally, the expression of non-conducting mutant KCa3.1
induced HEK293 cells proliferation not by enhancing Ca2+ entry
but via a direct interaction with ERK1/2 and c-jun N-terminal
kinase (JNK) signaling (Millership et al., 2011). Increasing num-
ber of reports show that certain K+ channels interact with sig-
naling molecules directly to regulate cellular signaling. Indeed,
the N- and C-terminal domains of hEag1 interacts with calmod-
ulin (Schönherr et al., 2000; Ziechner et al., 2006; Gonçalves and
Stühmer, 2010), cortactin (Herrmann et al., 2012); KCa3.1 chan-
nels interact with ERK1/2 (Millership et al., 2011), and HERG1
channels with the adaptor protein 14-3-3 (Kagan et al., 2002), Src
tyrosine kinase (Cayabyab and Schlichter, 2002), and the TNF-α
receptor (Wang et al., 2002). In addition, HERG channel proteins
have been shown to interact with integrins, thereby regulating cell
survival, adhesion and migration (Arcangeli and Becchetti, 2006;
Arcangeli, 2011).
The mechanisms that allow K+ channels to regulate cell
growth in cancer cell lines appear to be different from the ones
in normal cells. It has been reported that cancer cells express sev-
eral K+ channel isoforms that may be physiologically different
as compared to a wild type channel. For example, proliferation
of neuroblastoma cells is regulated by an oscillation balance of
expression of the full-length HERG 1a (Kv11.1a) isoform and the
N-deleted HERG 1b (Kv11.1b) (Crociani et al., 2003). It should
be also noted that the effects of K+ channels on cell proliferation
can involve their trafficking to the micro-domains within the cell.
It follows from the foregoing that the K+ channels influence
cell proliferation through as many mechanisms as the number of
their families and correspondent isoforms. That is undoubtedly
dependent on intrinsic features of each cell type and the isoforms
expressed.
K+ CHANNEL ACTIVITY DURING THE CELL CYCLE
A direct link between channel activity and particular stages of
the cell cycle has been reported. For example, in HeLa cells, the
K+ current-density increases duringM and G1 phases (Takahashi
et al., 1993), in unfertilized mouse oocytes, a large-conductance,
voltage-activated K+ channel (BKCa, 240 pS), is active through-
outM and G1 phases, and switches off during the G1-to-S
transition (Day et al., 1993). In Xenopus oocytes, the expressed
rat Eag (rEag1) rEag1 displays decrease in current-density in
meiotic phase induced by progesterone or by Mitosis promot-
ing factor (Brüggemann et al., 1997). Furthermore, the partial
synchronization of cells in G1 orM phases greatly increases the
current blockade by intracellular Na+ and Cs+ (Pardo et al.,
1998). In cancer cells, the K+ channels activity has been also
found to be cell cycle-dependant. For example, the activity of Eag1
is at high rate in G1 phase and decreases when cells enter S phase
(Ouadid-Ahidouch et al., 2004), and in neuroblastoma cells,
HERG current activity has been shown to be cell cycle-dependent
(Arcangeli et al., 1995).
The mechanisms linking the activity of each of these channels
to the cell cycle appear to be different and include regulation by
cytoskeletal elements (Camacho et al., 2000), the activation of
cyclin-dependent kinase 1 (CDK1) cyclin B (Brüggemann et al.,
1997), a cytoplasmic cell cycle that can run independently of the
nuclear cell cycle (Day et al., 1998), or channel trafficking.
Studies on K+ channels trafficking are increasingly emergent.
It has been suggested that Eag1 turns over rapidly (8–12 h) at
the cell surface (Weber et al., 2006). This process involves surface
expression followed by constitutive internalization and degrada-
tion in lysosomes (Kohl et al., 2011). Indeed, the Eag1 trafficking
has been reported to be regulated by several proteins including
cortactin, rabaptin-5 and epsin. Depletion of cortactin decreases
the number of functional Eag1 channels without altering their
open probability or conductance (Herrmann et al., 2012). These
authors suggest that cortactin connects Eag1 to the cytoskeleton.
Moreover, knockdown of rabaptin-5 reduces recycling rates of
Eag1 and leads to a reduction of Eag1 current-density (Ninkovic
et al., 2012). Eag1 also interacts with epsin that modulates its gat-
ing in rat brain (Piros et al., 1999). In view of these studies, the
expression of K+ channels during the cell could likely due to their
trafficking, although the involvement of this particular pathway
in cell proliferation is still not proven.
MOLECULAR MECHANISMS UNDERNEATH CELL CYCLE
REGULATION BY K+ CHANNELS (SEE TABLE 1 AND
FIGURE 1)
Aberrantly expressed cell cycle-related cyclins are highly associ-
ated with several cancer types including breast cancer (for review
Williams and Stoeber, 1996). As such, cyclin D1 is overexpressed
in ∼50% of breast cancers (Alle et al., 1998). Cyclin E is over-
expressed in 30% of breast tumors (Wang and Shao, 2006), and
the elevation of cyclin E is correlated with low levels of p27Kip1.
A decrease in the expression of p27Kip1 is strongly detected in
breast cancer tissues (for review, Alkarain et al., 2004). Further
genetic abnormalities also affect other CDKi, such as p16INK4a,
p15INK4b, and p57Kip2 (for review, Williams and Stoeber, 1996).
These observations led to consider the cell cycle regulators as
potential targets for selective inhibition in the treatment of can-
cer (Stone et al., 2012). The studies conducted so far show that
the modulation of these key proteins of the cell cycle correlates
with tumor development. Thus, it is clear that mitogenic factors
capable of modulating their expression positively can intensify the
process of carcinogenesis.
Despite K+ channel blockers modulate several proliferative
signaling pathways evidence for a direct mechanistic link between
K+ channels and cell cycle proteins remains sparse to date. Two
cell-cycle blocks are often observed when K+ channels are inhib-
ited: at G1 (early G1, late G1, G1/S transition) and at G2/M block
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Table 1 | K+ channels and cell cycle protein actors in cancers.
Cell line type K+ channel family Cell cycle phase Main actors References
MCF-7 (Breast cell line) hEag1 (Kv10.1;
KCNH1)
G1 and G1/S Cyclin D1
Cyclin E
P-Rb
No/CDK4
No/CDK2
No/p21waf1/cip1
No/p27kip1
Borowiec et al., 2011
LoVo (Human colon cell line) KCa3.1 (IK1; IKCa1;
KCNN4)
G2/M p-Cdc2 Lai et al., 2011
549 (Human lung cell line) Kv1.3 (KCNA3) G1 p21Waf1/Cip1
CDK4
Cyclin D3
Jang et al., 2011
U87 and U251 (Human glioma cell lines) Kir6.2 (KCNJ11)
ATP-sensitive
G1 p-ERK Huang et al., 2009
LNCaP
PC-3
DU-145
(Prostate cancer cell lines)
KCa3.1 (IK1; IKCa1;
KCNN4)
Prolif (G1/S) p2Cip1
No/p27Kip1
Lallet-Daher et al., 2009
MB (Medulloblastoma) CNS tumor EAG2 (Kv10.2;
KCNH5)
G2 Cyclin B1
p38 MAPK
Huang et al., 2012
HL-60 (leukemia cells) HERG1 (Kv11.1) G1 β-catenin,
cyclin-D1
c-myc
Zheng et al., 2011
with or without changes in the proportion of the cells enter-
ing S-phase. The G1 block is associated with a reduction of the
expression of cyclins (D and E), CDKs (4 and 2), pRb activation,
and overexpression of CDKi (p21Waf1/Cip1 and p27kip1), while
the block in G2/M is associated with a reduction of cyclin B1
expression or changes in Cdc2 (CDK1) phosphorylation.
The first studies used K+ channels pharmacological inhibitors
such as TetraEthyl Ammonium (TEA) and 4-Amino-Pyridine
(4-AP) to demonstrate that inhibition of the two K+ chan-
nels (Kv1.3 and Kv1.5) resulted in cell cycle arrest at G1 in
rat oligodendrocyte precursors (Ghiani et al., 1999; Chittajallu
et al., 2002). The authors proposed that changes in the mem-
brane potential (depolarization) could activate a signaling path-
way involving the p27kip1 and p21Waf1/Cip1 proteins expression.
Similar results were obtained when the membrane potential was
depolarized by increasing extracellular K+ (Renaudo et al., 2004).
In small cell lung cancer (SCLC, NCI-H209, and NCI-
H146) and leukemic (Jurkat) cell lines, inhibition of K+ chan-
nels has also been implicated in upregulation of the p27kip1
protein and a reduction in cyclin. A expression resulting in
cell arrest in G1/S phase transition (Renaudo et al., 2004).
Athough the mechanisms, by which K+ channels regulate cell
cycle in these cells remain undetermined, the authors suggested
involvement of cytoskeleton rearrangements due to cell volume
changes.
A detailed mechanism underlying the role of Eag1 in the cell
cycle was studied in MCF-7 breast cancer cells. In this work,
mitogenic stimulation [using serum or Insulin Growth Factor
1, (IGF-1)] up-regulates Eag1 expression and activity (Borowiec
et al., 2007). IGF-1 triggers cell cycle progression by increasing
expression of cyclin D1, cyclin E, CDK4, CDK2, and phospho-
rylation of pRb (Dufourny et al., 1997; Borowiec et al., 2011).
Inhibition of Eag1 by astemizole or by siRNA induced a decrease
in cyclin D1 expression along with a strong decrease of pRb phos-
phorylation and an arrest of the cells in G1 phase of cell cycle.
The effect of Eag1 inhibition was accompanied by a decrease of
cyclin E expression, the key regulator of the G1/S transition nec-
essary for cell entry into S phase (Skelding et al., 2011). However,
inhibition of Eag1 failed to modify the p21Waf1/Cip1, p27Kip1, and
CDK4/2 expression.
Interestingly, when Eag1 is inhibited, the cyclin D1 level is
below its level in serum-deprived cells, the condition known to
synchronize cells in G1 phase (Borowiec et al., 2011). It was thus
suggested that Eag1 control of the cell cycle could be upstream of
the G1 phase synchronization by serum deprivation. Indeed, the
cell cycle arrest site under Eag1 inhibition is both upstream of that
obtained by serum-deprivation, and downstream of that induced
by lovastatin, which synchronizes the cells in the early G1 phase
(Borowiec et al., 2011). Altogether, these results demonstrate that
Eag1 activation is positioned upstream of the upregulation of
both cyclins D1 and E expression.
It has been reported recently that the isoform 2 of Eag (Eag2) is
essential for mitotic entry of medulloblastoma (MB) cells (Huang
et al., 2012). Indeed, the authors observed a correlation between
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temporal Eag2 translocation to plasma membrane and mitotic
entry from the late G2 phase concurrent with an increase of
outward K+ current during mitosis. Moreover, Eag2 knockdown
accumulates cells in G2/M in association with a strong decrease
of cyclin B1 (essential for G2/M transition), but fails to affect the
expression of cyclin A, cyclin D1, cyclin E, and CDK1 (Huang
et al., 2012). The G2/M arrest is due to an alteration in cell
volume control that is linked to hyperactivation of p38 MAPK
pathway without any effect on p53 expression. It has been then
hypothesized that Eag2 regulates cell volume during the MB cell
cycle progression (Habela and Sontheimer, 2007; Boucrot and
Kirchhausen, 2008).
Ca2+-activated K+ channels (KCa) also regulate cell cycle
progression. KCa3.1 is one of the KCa channels that regulate
proliferation and migration of cancer cells (Ouadid-Ahidouch
et al., 2004; Faouzi et al., 2010; Catacuzzeno et al., 2012). KCa3.1
controls G1 (mainly late G1) phase, G1/S transition, and G2/M
phase. In breast, prostate and endometrial cancers, KCa3.1 reg-
ulates G1 and G1/S transition (Ouadid-Ahidouch et al., 2004;
Wang et al., 2007b; Lallet-Daher et al., 2009). Pharmacological or
genetic blockade of KCa3.1 increases p21Waf1/Cip1 expression and
decreases the expression of cyclin E. According to the “potential
membrane model,” activation of K+ channels amplifies the Ca2+
signals by hyperpolarizing the membrane potential, thus increas-
ing driving force for Ca2+ influx, which, in turn, activates Ca2+-
dependent transcriptional factors leading to expression of G1
cyclins and CDK proteins (Roderick and Cook, 2008). Consistent
with this notion, it has been shown that TRPV6 may be the major
provider of passive Ca2+ influx in response to the hyperpolariza-
tion associated with KCa3.1 channels activation in prostate cancer
cell line (Lallet-Daher et al., 2009). In breast cancer cells, it has
been demonstrated that Eag1, by regulating membrane potential,
controls Ca2+ entry through Orai1 channels (Hammadi et al.,
2012).
KCa3.1 channels also control the cell volume and regulate G1/S
transition and G2/M phases (Tao et al., 2008; Lai et al., 2011). In
mouse mesenchymal stem cells, KCa3.1 channels associated with
Cl− -volume channels regulate cell cycle progression by modulat-
ing cyclin D1 and cyclin E expression (Tao et al., 2008). However,
in human colon cancer cells (LoVo), their inhibition accumulates
cells in G2/M phase and increases the phosphorylation of Cdc2
(Lai et al., 2011).
In summary, several K+ channels have been implicated in pro-
liferation of various types of cancers cells including Kv (Menéndez
et al., 2010; Asher et al., 2011; Jang et al., 2011; Jeon et al.,
2012), KCa (Jäger et al., 2004; Faouzi et al., 2010; Oeggerli et al.,
2012), Kir (Huang et al., 2009), K2P (Bayliss and Barrett, 2008;
Innamaa et al., 2013). Higher expression or activity of these chan-
nels in cancer cells appears to correlates with deregulation of cell
cycle protein expression and/or function leading to enhanced cell
proliferation.
CONCLUSIONS
In summary, K+ channels are often overexpressed in tumor cells
and regulate proliferation. They are needed to control specific
checkpoints in the cell cycle progression (early G1, the G1/S
and G2/M transitions). Accordingly, several K+ channels exhibit
a cell-cycle-dependent expression and activity. In addition,
cell cycle progression is often accompanied by oscillations of
Cl− channel expression and Ca2+ signals that regulate cell
proliferation. Recent evidence shows the involvement of aqua-
porin in cell proliferation. The links between K+ channels and
cell-cycle machinery (cyclins, CDKs, and CDKi) start to emerge
(Figure 1). However, we are still far from full understanding the
complex mechanistic link between channel expression/activity
FIGURE 1 | Schematic illustration of the role of K+ channels during cell
cycle progression and proliferation. (1) Membrane potential model:
during progression into G1 phase, the membrane potential becomes
hyperpolarized relative to the normal resting potential. The hyperpolarization
relates to Kv channels activation (for example Kv1.3, Eag1) in early G1 and
to Ca2+−activated K+ channels (for example KCa3.1) activation in late G1
and/or G1/S transition. Multiple growth factors in serum have been
well-described to play an important role in initiating G1 progression to the S
phase of the cell cycle, in which Ca2+ influx is a major determinant in
serum-induced DNA synthesis. Growth factors (for example IGF-1) binding
to the receptor tyrosine kinases [RTKs; for example, Insulin growth factor
receptor (IGF-1R)] can activate effectors [Extracellular signal-Regulated
Kinase 1/2 (ERK1/2), phosphatidylinositol 3-kinase (PI3K)] that increase the
expression and the activity of K+ channels inducing a hyperpolarization of
the membrane potential (MP). Moreover, RTKs also activate phospholipase
C (PLCγ) to promote the generation of inositol-1,4,5-trisphosphate (InsP3)
and the release of Ca2+ from the endoplasmic reticulum (ER) into the
cytosol. Ca2+ enters across plasma membrane by store-operated capacitive
Ca2+ entry (SOCE) through the ORAI1 (Hammadi et al., 2012) or ORAI3
(Faouzi et al., 2011) channels, through TRP Ca2+ channels (for example
TRPC1, El Hiani et al., 2009), or via the constitutively active TRPV6. The
Ca2+ entry, in turn, regulates the activity and/or the expression of
Ca2+-activated K+ channels (for example KCa3.1), which maintains the
hyperpolarization promoting a significant Ca2+-entry. The increase in [Ca2+]i
triggers the activation of Ca2+-dependent signaling enzymes that may act
by regulating the expression or activity of the transcription factors (TF),
such as FOS, JUN, NFAT, C-MYC leading to the expression of cyclins and
CDKs and the inhibition of the CDK inhibitor proteins (p27KIP1 and
p21waf1/cip1). (2) Volume control: K+ channels in association with chloride
channels regulate cell cycle progression by controlling the cell volume. For
example, Eag2 channels control M phase by regulating the expression of
cyclin B1 through the p38 MAP Kinase pathway. (3) Non-conducting roles:
K+ channels may also promote cell proliferation independently of their ion
permeation function. For example: Eag1 and KCa3.1 induce cell proliferation
by (direct or indirect) interaction with MAP kinase signaling pathways (p38
for Eag1, ERK1/2, and JNK for KCa3.1). MP: membrane potential, (vol.
CTRL): volume control, (PM): plasma membrane.
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and signaling in proliferating cells. The detailed understanding of
the role of K+ channels and their connection with Ca2+ signals in
regulation of cell cycle proteins and/or transcription factors will
offer significant opportunities to develop more specific tools for
cancer therapy.
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